The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cambridge Structural Database: a quarter of a million crystal structures and rising
Allen, F. H. (2002) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768102003890 · Cited by 9,898
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.026 · Cited by 1,487
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754
Chemical phylogenetics of histone deacetylases
Bradner, J. E., West, N., Grachan, M. L., Greenberg, E. F., Haggarty, S. J., Warnow, T., & Mazitschek, R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.313 · Cited by 720
Class II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1759 · Cited by 659
Fleetwood, A. J., Lawrence, T., Hamilton, J. A., & Cook, A. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5245 · Cited by 607
Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566
Defining GM-CSF– and Macrophage-CSF–Dependent Macrophage Responses by In Vitro Models
Lacey, D. C., Achuthan, A., Fleetwood, A. J., Dinh, H., Roiniotis, J., Scholz, G. M., Chang, M. W., Beckman, S. K., Cook, A. D., & Hamilton, J. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103426 · Cited by 528
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.260501497 · Cited by 517
The International Stroke Genetics Consortium (ISGC), Bellenguez, C., the Wellcome Trust Case Control Consortium 2 (WTCCC2), Bevan, S., Gschwendtner, A., Spencer, C. C. A., Burgess, A. I., Pirinen, M., Jackson, C. A., Traylor, M., et al. (2012) · Nature Genetics · doi:10.1038/ng.1081 · Cited by 416
Bottomley, M. J., Lo Surdo, P., Di Giovine, P., Cirillo, A., Scarpelli, R., Ferrigno, F., Jones, P., Neddermann, P., De Francesco, R., Steinkühler, C., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803514200 · Cited by 312
Class II histone deacetylases: Structure, function, and regulation
Bertos, N. R., Wang, A. H., & Yang, X.-J. (2001) · Biochemistry and Cell Biology · doi:10.1139/bcb-79-3-243 · Cited by 276
SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes
Berdeaux, R., Goebel, N., Banaszynski, L., Takemori, H., Wandless, T., Shelton, G. D., & Montminy, M. (2007) · Nature Medicine · doi:10.1038/nm1573 · Cited by 266
Schuetz, A., Min, J., Allali-Hassani, A., Schapira, M., Shuen, M., Loppnau, P., Mazitschek, R., Kwiatkowski, N. P., Lewis, T. A., Maglathin, R. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707362200 · Cited by 257
Human HDAC7 Histone Deacetylase Activity Is Associated with HDAC3in Vivo
Fischle, W., Dequiedt, F., Fillion, M., Hendzel, M. J., Voelter, W., & Verdin, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104935200 · Cited by 232
Histone Deacetylase Inhibitors: Current Status and Overview of Recent Clinical Trials
Ma, X., Ezzeldin, H. H., & Diasio, R. B. (2009) · Drugs · doi:10.2165/11315680-000000000-00000 · Cited by 227
Dormán, G., Cseh, S., Hajdú, I., Barna, L., Kónya, D., Kupai, K., Kovács, L., & Ferdinandy, P. (2010) · Drugs · doi:10.2165/11318390-000000000-00000 · Cited by 178
Mielcarek, M., Benn, C. L., Franklin, S. A., Smith, D. L., Woodman, B., Marks, P. A., & Bates, G. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027746 · Cited by 163
Endogenous modulators and pharmacological inhibitors of histone deacetylases in cancer therapy
Spiegel, S., Milstien, S., & Grant, S. (2011) · Oncogene · doi:10.1038/onc.2011.267 · Cited by 159
Regulatory signal transduction pathways for class IIa histone deacetylases
Parra, M., & Verdin, E. M. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.004 · Cited by 147
Etiology and Outcome of Community-Acquired Lung Abscess
Takayanagi, N., Kagiyama, N., Ishiguro, T., Tokunaga, D., & Sugita, Y. (2010) · Respiration · doi:10.1159/000312404 · Cited by 142
Current perspective of TACE inhibitors: A review
DasGupta, S., Murumkar, P. R., Giridhar, R., & Yadav, M. R. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.11.067 · Cited by 127
Matrix Metalloproteinase Inhibitors: New Challenges in the Era of Post Broad-Spectrum Inhibitors
Nuti, E., & Tuccinardi, T. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039706 · Cited by 109
Histone deacetylase inhibitors: Apoptotic effects and clinical implications (Review)
Emanuele (1992) · International Journal of Oncology · doi:10.3892/ijo_00000049 · Cited by 100
Brockschmidt, F. F., Heilmann‐Heimbach, S., Ellis, J. A., Eigelshoven, S., Hanneken, S., Herold, C., Moebus, S., Alblas, M. A., Lippke, B., Kluck, N., et al. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10708.x · Cited by 77
Histone Deacetylase 9 (HDAC9) Regulates the Functions of the ATDC (TRIM29) Protein
Yuan, Z., Peng, L., Radhakrishnan, R., & Seto, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179333 · Cited by 77
Quinti, L., Chopra, V., Rotili, D., Valente, S., Amore, A. M., Franci, G., Meade, S., Valenza, M., Altucci, L., Maxwell, M. M., et al. (2010) · PLoS Currents · doi:10.1371/currents.rrn1172 · Cited by 39
Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells
Kewitz, S., Bernig, T., & Staege, M. S. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.02.021 · Cited by 21
Cited by
Targeting macrophages: therapeutic approaches in cancer
Cassetta, L., & Pollard, J. W. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.169 · Cited by 2,048
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Falkenberg, K. J., & Johnstone, R. W. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4360 · Cited by 1,564
New and emerging HDAC inhibitors for cancer treatment
West, A. C., & Johnstone, R. W. (2014) · Journal of Clinical Investigation · doi:10.1172/jci69738 · Cited by 1,404
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
Huang, Y., Su, R., Sheng, Y., Dong, L., Dong, Z., Xu, H., Ni, T., Zhang, Z. S., Zhang, T., Li, C., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.03.006 · Cited by 877
Metadata
- Authors
- Lobera, M., Madauss, K. P., Pohlhaus, D. T., Wright, Q. G., Trocha, M., Schmidt, D. R., Baloglu, E., Trump, R. P., Head, M. S., Hofmann, G. A., Murray-Thompson, M., Schwartz, B., Chakravorty, S., Wu, Z., Mander, P. K., Kruidenier, L., Reid, R. A., Burkhart, W., Turunen, B. J., Rong, J. X., Wagner, C., Moyer, M. B., Wells, C., Hong, X., Moore, J. T., Williams, J. D., Soler, D., Ghosh, S., & Nolan, M. A.
- Venue
- Nature Chemical Biology
- Published
- 2013-03-24
- Volume
- 9
- Issue
- 5
- Pages
- 319-325
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2074006690
- Cited by
- 376
- References
- 33
- FWCI
- 9.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.